These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7948135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
    Yei S, Mittereder N, Tang K, O'Sullivan C, Trapnell BC.
    Gene Ther; 1994 May; 1(3):192-200. PubMed ID: 7584081
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ, McElvaney NG, Chu CS, Rosenfeld MA, Mastrangeli A, Hay J, Brody SL, Eissa NT, Danel C, Jaffe HA.
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [Abstract] [Full Text] [Related]

  • 5. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL, Metzger M, Danel C, Rosenfeld MA, Crystal RG.
    Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
    [Abstract] [Full Text] [Related]

  • 6. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA, Chu CS, Seth P, Danel C, Banks T, Yoneyama K, Yoshimura K, Crystal RG.
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [Abstract] [Full Text] [Related]

  • 7. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR.
    N Engl J Med; 1995 Sep 28; 333(13):823-31. PubMed ID: 7544439
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O, Ashbourne Excoffon KJ, Henning P, Melin P, Norez C, Gonzalez G, Karp PH, Magnusson MK, Habib N, Lindholm L, Becq F, Boulanger P, Zabner J, Hong SS.
    Hum Gene Ther; 2010 Mar 28; 21(3):251-69. PubMed ID: 19788389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E.
    Hum Gene Ther; 1996 Jan 28; 7(1):79-87. PubMed ID: 8825871
    [Abstract] [Full Text] [Related]

  • 15. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC, Knowles MR, Johnson LG, Olsen JC, Pickles R, Wilson JM, Engelhardt J, Yang Y, Grossman M.
    Hum Gene Ther; 1994 May 28; 5(5):615-39. PubMed ID: 7519885
    [Abstract] [Full Text] [Related]

  • 16. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
    Bout A, Imler JL, Schultz H, Perricaudet M, Zurcher C, Herbrink P, Valerio D, Pavirani A.
    Gene Ther; 1994 Nov 28; 1(6):385-94. PubMed ID: 7584104
    [Abstract] [Full Text] [Related]

  • 17. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
    Hay JG, McElvaney NG, Herena J, Crystal RG.
    Hum Gene Ther; 1995 Nov 28; 6(11):1487-96. PubMed ID: 8573621
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG, Jaffe A, Brody S, Mastrangeli A, McElvaney NG, Rosenfeld M, Chu CS, Danel C, Hay J, Eissa T.
    Hum Gene Ther; 1995 May 28; 6(5):643-66. PubMed ID: 7578401
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.